Bears are Losing Control Over ASLAN Pharmaceuticals Ltd. , Heres Why Its a Buy Now - Yahoo New Zealand News
ASLNDelisted Stock | USD 0.60 0.03 4.76% |
About 61% of Aslan Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Aslan Pharmaceuticals suggests that many traders are alarmed regarding Aslan Pharmaceuticals' prospects. Aslan Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Aslan Pharmaceuticals. Many technical investors use Aslan Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Aslan |
Bears are Losing Control Over ASLAN Pharmaceuticals Ltd. , Heres Why Its a Buy Now Yahoo New Zealand News
Read at news.google.com
Aslan Pharmaceuticals Fundamental Analysis
We analyze Aslan Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aslan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aslan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
Aslan Pharmaceuticals is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Aslan Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aslan Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Aslan Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aslan Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Aslan Pharmaceuticals Related Equities
CTMX | CytomX Therapeutics | 6.25 | ||||
IOBT | IO Biotech | 5.63 | ||||
LYRA | Lyra Therapeutics | 5.26 | ||||
ANTX | AN2 Therapeutics | 3.73 | ||||
AGIO | Agios Pharm | 2.76 | ||||
ACRV | Acrivon Therapeutics, | 2.65 | ||||
ASMB | Assembly Biosciences | 2.63 | ||||
CGEM | Cullinan Oncology | 1.83 | ||||
GLUE | Monte Rosa | 1.65 | ||||
ACHL | Achilles Therapeutics | 0.94 | ||||
AVTE | Aerovate Therapeutics | 0.75 | ||||
ERAS | Erasca | 0.72 | ||||
CMPX | Compass Therapeutics | 0.67 | ||||
GPCR | Structure Therapeutics | 0.79 | ||||
NAMS | NewAmsterdam Pharma | 1.00 | ||||
IVA | Inventiva | 1.12 | ||||
MLYS | Mineralys Therapeutics, | 1.42 | ||||
ADAG | Adagene | 2.20 | ||||
TIL | Instil Bio | 2.83 | ||||
ANEB | Anebulo Pharmaceuticals | 4.11 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |